We have previously developed an in vivo model of leukemogenesis utilizing mice reconstituted with genetically modified bone marrow cells. Based on those studies, a new single gene retroviral vector has been engineered which efficiently transfers vmyc into immature murine bone marrow cells. All reconstituted mice developed leukemia with a short latency period (5-11 weeks). In addition to hyperproliferation associated with elevated levels of PCNA, extensive apoptosis was also observed in all leukemic animals with p53 accumulating in the apoptotic cells. Whereas bax encoded protein, an effector of p53 apoptotic activity was detected in apoptotic cells, p21
Introduction
Oncogenes can be used experimentally to induce leukemia in animal models. 1, 2 This tends to reflect oncogene activation in human tumors. Activation of c-myc is found in a variety of human tumors, its deregulation often being one component of multistage carcinogenesis. 3, 4 Aberrant expression of c-myc has been implicated in a wide variety of experimentally induced tumors. 5 The precise mechanism(s) by which myc activation contributes to oncogenesis is not completely defined. Myc is a DNA-binding phosphoprotein which can function as a transcriptional activator. 3, 6 Expression of c-myc is an important signal both for entry into, and continued passage through, the cell cycle. 7, 8 It has also been shown that cmyc expression can induce apoptosis. 8, 9 The function of cmyc in promoting either cell division or apoptosis appears to be modulated by the expression of other genes such as bcl-2 and p53 as well as by certain growth factors. [10] [11] [12] [13] To investigate the impact of deregulated myc expression on hematopoiesis we have utilized an in vivo system utilizing mice reconstituted with ex vivo manipulated bone marrow cells. In previous studies with v-myc and v-erb-B, mice developed both myeloproliferative disease and leukemia at high frequency. 1, 2 In the case of v-myc, these previous studies revealed that in vivo expression of v-myc driven by the MoMLV/MSV-LTR was apparently suppressed by additional
Retroviral vectors and virus production
The LK vector was engineered by deletion of neo sequences from the parental LNL6 vector 15 and introduction of a polylinker 5Ј AATTCAGATCTGAGCTCCCCGGGGATCCTCTA-GAA 3Ј (Figure 1 ). v-myc cDNA 16 or a ␥-actin promoterdriven v-myc expression cassette was inserted into the HindIII/EcoRI site of LK to generate new vectors, termed Lvmyc2 and LNAv-myc, respectively ( Figure 1 ). pLK, pLv-myc2 or pLNAv-myc DNA was introduced into the ⌿ packaging line 17 by calcium phosphate precipitation together with pMolNeo DNA 1 at a ratio of 20:1 (w/w) followed by selection in 500 g/ml G418. Individual G418 resistant colonies were expanded. The relative viral titers produced by individual clones were examined by viral RNA-blot analysis and probing with 32 P-labelled v-myc-specific cDNA probe. 16 The clones of apparent highest titer were further examined by analyzing their ability to transform Rat-1 cells in vitro. 1 The ⌿2AV viral
Figure 1
Proviruses used in the reconstitution experiments. The constructs used in these experiments are based on the pLNL6 vector 15 (a) in which the neo as well as some additional sequence was deleted and polylinkers inserted to produce pLK (b). pLNAv-myc (c) and pLvmyc2 (d) were produced by the insertion of a ␥-actin promoter driven v-myc expression cassette or a 1.7 kb v-myc fragment from MC29 into pLK, respectively. 16 Shaded boxes, LTRs, ⌿ + packaging region; thick vertical line, viral splice donor site.
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producer in which the packaged provirus contains neo and the ␥-actin promoter upstream of v-myc, used previously in bone marrow reconstitution studies, 1 was used as a control. Virus-producing cells were grown in Dulbecco's modified Eagle's medium (DMEM; Gibco, Gaithersburg, MD, USA) supplemented with 10% fetal calf serum, penicillin (100 U/l) and streptomycin (50 g/ml). The viral producers used in the bone marrow infection were negative for the generation of replication-competent retroviruses (RCR), determined by marker rescue assay.
18 3T3 cells carrying neo 15 were infected with virus-containing medium from producer cell lines and then exposed to G418 for 2 weeks. Conditioned medium derived from G418-resistant cells was then used for infection of NIH3T3 cells. G418-resistant colonies were scored after 10 days. In no case was RCR detected in the producer cells nor in cell cultures, including bone marrow cultures derived from reconstituted mice.
Bone marrow reconstitution
Bone marrow cells were harvested from the femurs of 8-weekold female Balb/C mice that had been treated 4 days previously with 150 mg/kg 5-fluorouracil (5-FU). Bone marrow cells were incubated for 48 h with virus-containing supernatant harvested from 80-90% confluent plates of viral producer cells. The infection was conducted in Iscove's modified Dulbecco's medium (IMDM) supplemented with 1 mg/ml bovine serum albumin (Sigma Aldrich, Australia), 30 g/ml transferrin (Sigma), 8 g/ml polybrene (Sigma), 20% WEHIcell conditioned medium (WCM), 19 10 ng/ml of murine recombinant stem cell factor (SCF; Genzyme Diagnostics, Cambridge, MA, USA), 10 ng/ml of murine recombinant IL-6 (Genzyme), 2 mM glutamine, penicillin (50 U/l), streptomycin (50 g/ml) and 20% fetal bovine serum (FBS). In certain cases, bone marrow cells were infected in the absence of SCF and IL-6 ('sub-optimal' conditions). After infection, cells were washed once in IMDM supplemented with 2% FBS and resuspended in IMDM.
Lethally-irradiated recipient mice (8.5 Gy) were injected intravenously with either low-or high-dose cell numbers in the range 1.5 × 10 5 -2 × 10 6 cells. Twenty animals in three separate experiments were reconstituted with Lv-myc infected cells, 12 animals with the LNAv-myc infected cells in two of the three separate experiments, along with 20 LK control animals in the three separate experiments. In addition, 10 animals in two separate experiments were analyzed under 'suboptimal' conditions. Cells FDC-P1 cells 20 were grown in RPMI 1640 (Gibco) supplemented with 10% FCS and 10% WCM. Prior to bone marrow transplantation, cells were cultured as described above. Following retroviral infection, bone marrow cells were cultured in RPMI 1640 supplemented with 0.2 M glutamine, penicillin (100 U/l), streptomycin (50 g/l), 10% FCS and 20% WCM. Cells were fed at weekly intervals by a half exchange of medium, non-adherent cells being re-added following centrifugation. Cell numbers and morphology were assessed at the time of feeding. Cultures were terminated when more than 90% of the non-adherent cells seen on stained cytospin preparations were monocyte/macrophages. Survival and growth of cells in cultures free of exogenously added growth factors was also assayed. Non-adherent cells (10 5 cells/ml) were washed with culture medium and grown for 24 h without the addition of WCM. Cell viability was assessed by trypan blue exclusion. Clonogenic ability of bone marrow cells grown in the presence or absence of growth factors for 24 h was examined and PCR analysis of proviral DNA in individual colonies was performed (see below).
Apoptosis was induced in tissue culture cell lines by collecting non-adherent cells and seeding in culture medium lacking WCM. Total cell number, cell viability and cell morphology were examined 24 or 48 h later. DNA fragmentation, a marker of apoptosis, 21 was assessed by gel electrophoretic examination of DNA in lysates, as previously described. 22 Progenitor clonogenic assay Non-adherent cells derived from infected bone marrow cultures (5 × 10 4 cells per ml) were added to 0.8% methylcellulose with 25% horse serum, 20% WCM in DMEM. In this case, CFU-GMs were scored at day 7. In addition, CFU-GMs, CFU-GEMMs and BFU-Es were assayed by adding 20% WCM and recombinant murine erythropoietin (Sigma) (2 U/ml), recombinant murine IL-6 (100 ng/ml) and ␤-mercaptoethanol (10 −4 M) into 0.8% methylcellulose and all colonies were scored at day 10-14. CFU-GMs, CFU-GEMMs and BFU-Es were identified by morphological criteria and the latter two by both morphology and benzidine staining.
Detection of proviral DNA in individual colonies
Between 10 and 20 single colonies were picked from methylcellulose cultures and immediately resuspended in PCR buffer containing nonionic detergent as previously described. 23 Lysates were incubated with proteinase K for 1 h at 50°C and then 10 min at 94°C to inactivate the enzyme. These lysates were incubated with 100 ng of primers 1 and 2 and 0.5 U of Taq-polymerase (Amplitaq; Perkin Elmer, CA, USA); 50 M dNTPs, 80 mM Tris (pH 8.0) and 5 mM MgCl 2 . The primers used for PCR reaction were as follows:
The thermal cycling program used was one cycle of 94°C for 4 min, then 35 cycles of 94°C for 30 s, 63°C for 1 min and 72°C for 1 min 30 s, followed by an elongation step at 74°C for 10 min. The products were separated on a 1.5% agarose gel.
Analysis of proviral integration and gene expression in the hematopoietic tissues of reconstituted animals Genomic DNA and cellular RNA were isolated from frozen spleens and processed for probing as previously described. 1 Blots were probed with 32 P-labelled v-myc-specific cDNA probe.
Expression of v-myc was determined by reverse transcriptase-based PCR (RT-PCR). RNA samples (1 g) were incubated for 40 min at 37°C in 40 mM Tris (pH 7.5). 1.5 mM MgCl 2 , and 10 mM NaCl containing 2 U of RNase-free DNase (Promega). Samples were then boiled for 15 min. cDNA syn-thesis was performed in a 20 l reaction mixture containing 50 mM Tris (pH 8.3), 50 mM KCl, 5 mM MgCl 2 , 10 mM DTT, 0.5 mM of each dNTP, 40 U of RNasin (Promega, Madison, WI, USA), 100 U of MoMLV RTase (Promega) and 0.1 M vmyc-specific primer 4. Reactions were incubated at 37°C for 40 min, then 94°C for 3 min to inactivate the enzyme. This reaction mix was used for PCR-amplification of cDNA. Reactions were performed in 100 l of reaction mixture containing 0.1 M of both v-myc-specific primers (primers 3 and 4), 0.1 mM of each dNTP, 1.5 mM MgCl 2 and 0.5 U of Taq-polymerase. The thermal cycling program used was 4 min at 94°C for one cycle, then 30 s at 68°C, 30 s at 74°C and 30 s at 94°C for 35 cycles, and a final elongation step of 3 min at 74°C. PCR reactions with the RT-step omitted were also performed as a control for possible DNA amplification. In some experiments PCR products resolved on a 2% agarose gel were transferred onto Hybond N membrane and probed with 
Morphological studies and immunohistochemical assays
Tissues were fixed in 10% neutral-buffered formalin and then embedded in paraffin. Tissue sections (5 m) were mounted on poly-L-lysine-coated glass slides. Paraffin was removed by heating at 90°C and washing three times in xylene. Sections were rehydrated in absolute ethanol for 15 s and a series of graded ethanol/H 2 O solutions followed by PBS. Sections were stained with hematoxylin-eosin for morphological study.
For immunohistochemistry, endogenous peroxidase activity was quenched using 2% (v/v) H 2 O 2 for 5 min. Immunohistochemical staining was performed using mouse monoclonal proliferating cell nuclear antigen (PCNA)-specific antibody (PC10; Santa Cruz Biotechnology, CA, USA). SIH universal anti-mouse kit (Sigma Diagnostics) was used for the detection of antibody binding. Either 3-amino-9-ethylcarbazole (red color) or DAB were used as substrates for horseradish peroxidase. Mouse IgG2a (Sigma Immunochemicals) was used as an isotype control. Cells showing strong distinct nuclear staining were registered as positive. The proliferative index (PI) is the average number of positively stained cells per field with 20 random fields being counted. p53-specific staining was performed using PAb246 (Oncogene Science, Uniondale, NY, USA). Mouse IgG 1 murine polyclonal antibody (Becton Dickinson, San Jose, CA, USA), was used as an isotype control. p21
Waf1 and bax were visualized using polyclonal IgG (Santa Cruz Biotechnology). As per the antigen retrieval protocol (Oncogene Science), sections were treated in 6 M urea for 20 min in a microwave before application of the antibody.
In situ quantitation of apoptotic cell death DNA fragmentation was examined on paraffin-embedded sections by terminal transferase labelling of DNA breaks with biotin-labelled dUTP (TUNEL). 24 Apoptotic cells were categorised and counted for each microscopic field. In negative controls, terminal transferase was omitted.
Results

Characterization of a novel Lv-myc2 virus
Previous studies showed that in vivo expression of v-myc driven by the Mo-MLV/MSV-LTR was suppressed by additional sequences which included neo and an internal ␥-actin promoter. In contrast, v-myc was efficiently expressed within a spontaneously generated recombinant single gene retrovirus termed Lv-myc in which these additional sequences have been deleted by recombination. 1, 14 The design of the engineered Lv-myc2 was based on this spontaneously arising virus (Figure 1) . A retroviral vector LK was constructed by replacing neo within LNL6 15 with a polylinker (Figure 1 ). The resultant vector is 4.7 kb and contains a multiple cloning site and all features of LNL6 except the neo gene and the following sequences between neo and the HindIII site: FCV (env C) pol region, some unknown intervening sequence of approximately 20 bp and part of the mos sequence of MSV (Genebank LNL6 sequence). Lv-myc-2 was constructed by the insertion of HindIII/XhoI 1.7 kb v-myc cDNA fragment derived from PAB 16 into HindIII linearized LK ( Figure 1 ). The ⌿ 2 Lv-myc2 producer clone used in this study was selected as the highest titer viral producer, assessed by dot blot analysis of RNA isolated from the virus-containing supernatant (data not shown). As LV-myc2 did not contain a selectable marker gene, but rather the v-myc oncogene, titer was determined by the ability of Lv-myc2 to transform Rat-1 cells. 1 ⌿2Lv-myc2 exhibited relatively high transforming capacity producing 1 × 10 5 focus-forming units per ml, compared to the previously used ⌿2LNAv-myc producer: 3 × 10 4 focusforming units per ml. 1 In our experience, transforming titer is generally one log lower than drug selection titer. A single 3.5 kb transcript was detected by Northern analysis of ⌿2Lv-myc2-derived RNA, indicating efficient LTR-driven proviral expression and that no apparent recombination had occurred in the viral producer cell lines (data not shown). In addition, the expected 3.5 kb v-myc-specific transcript was detected in Lv-myc2-infected myeloid progenitor FDC-P1 cells (data not shown).
V-myc was efficiently expressed in Lv-myc2-infected bone marrow cells as detected by RT-PCR (data not shown). Lvmyc2 provirus was detected by PCR in an average of 70-80% of the CFU-GMs derived from Lv-myc2-infected bone marrow cells. A similar high transduction efficiency was observed in LK-infected bone marrow (Table 1) .
Two opposite effects, hyperproliferation and apoptosis, are induced by Lv-myc2 in primary bone marrow cells in vitro When cultured in WCM, Lv-myc2-infected bone marrow cells exhibited an increased number of CFU-GM relative to LKinfected bone marrow cultures (233 ± 14 vs 150 ± 10; 135 ± 4 vs 98 ± 5) ( Table 1) . When bone marrow cells were temporarily (24 h) deprived of WCM just before CFU-GM analysis, the number of CFU-GMs decreased in both LK-and Lv-myc2-infected bone marrow cultures. This reduction was more marked in Lv-myc2-bone marrow (21 ± 3 vs 233 ± 14; 13 ± 3 vs 135 ± 4) than in LK-bone marrow (81 ± 5 vs 150 ± 10; 50 ± 5 vs 98 ± 5) ( Table 1 ). PCR analysis of individual colonies revealed a significant decrease in the proportion of virus-positive colonies in Lv-myc2-infected bone marrow while depletion of virus-positive colonies was not observed in LK- Cellularity was obtained by counting the cell number per femur and cell viability determined by trypan blue exclusion. Clonogenic capacity was analyzed by plating 5 × 10 4 bone marrow cells from LK or Lv-myc2 mice in 1 ml methylcellulose cultures. Colonies derived from different progenitors were scored and total progenitor number in the bone marrow was calculated as the number of colonies per plated cells × total number of viable cells per femur. Lvmyc2 mice were sacrificed at disease onset 8-11 weeks following reconstitution with one LK animal sacrificed with each Lv-myc2 animal. Statistical analysis was performed using the Student's t-test and data is presented as the mean ± standard deviation, with P Ͻ 0.005* for all comparisons between LK and Lv-myc2 mice.
infected cultures. Lv-myc2-positive myelomonocytic progenitor cells thus appear to be more sensitive to growth factor withdrawal than LK-infected progenitor cells. Table 3 Hyperproliferation and apoptosis in hematopoietic organs of Lv-myc2 reconstituted mice which developed leukemia PCNA-specific staining and the TUNEL assay were performed in situ as described in Materials and methods. The percentage of either PCNA or TUNEL-positive cells was determined by counting a total of 500 cells in each of 10 high power light microscopic fields per section. Results shown are derived from groups of five representative mice. For the remaining 10 mice from each group, hyperproliferation and apoptosis were not quantitated, however, increased levels of both were apparent on PCNA and TUNEL-stained sections from these animals. Statistical analysis was performed using the Student's t-test, P Ͻ 0.005* for all comparisons between LK and Lv-myc2 mice.
Integration and expression of v-myc in reconstituted animals
Proviral sequences were detected by PCR analysis using ⌿-specific primers in bone marrow samples of all 15 Lv-myc2 mice (seven are shown in the Figure) , three out of five surviving animals in the third experiment (see below) and 12 representative LK-reconstituted mice (Figure 2a) . Proviral DNA was also detected by Southern analysis of genomic DNA isolated from the spleens of reconstituted animals. KpnI digestion which cleaves the Lv-myc2 provirus within each LTR revealed the expected 3.5 kb proviral fragment detected by a 32 P-labelled v-myc-specific probe. A representative experiment is Figure 2c . Similar results were found in the further series of five mice, in which case three animals out of the five, surviving irradiation developed leukemia (data not shown). By contrast, v-myc expression was detected in only eight of the 12 LNAv-mycreconstituted mice (representative examples are shown in Figure 2c ). This correlates with previous results 1 and indicates that Lv-myc-2 is more efficiently expressed in terms of the consistency of expression in vivo than LNAv-myc in bone marrow reconstitution experiments.
Leukemia induced by Lv-myc2 is accompanied by extensive hyperproliferation and apoptosis
In our previous reconstitution studies, v-myc expression in LNAv-myc-reconstituted mice induced both myeloproliferative disease and leukemia. 1 When lethally irradiated mice were reconstituted with Lv-myc2-infected bone marrow cells, all mice (20 mice were reconstituted in three separate experiments) became moribund within 5-11 weeks of reconstitution. Post-mortem examination revealed significant enlargement of the spleen (4-12-fold) as well as pale bone marrow. Histopathological analysis revealed abnormal architecture in the spleen and bone marrow along with a reduction of the red blood cell compartment and megakaryocyte numbers in the bone marrow (data not shown). All leukemic animals exhibited extramedullary hematopoiesis within the spleen and liver, as well as increased numbers of immature cells and decreased heterogeneity of mature cells in the bone marrow (data not shown). Phenotypic and cell morphology analysis indicated acute myeloid leukemia in all mice except one which developed T cell leukemia (data not shown). Thus v-myc expression in Lv-myc2-reconstituted mice induced a phenotype similar though with a dramatically faster latency (see below) to that observed in LNAv-myc-reconstituted mice. 1 All but one of the leukemic animals which were characterized with multiple features of hyperplastic disorders, exhibited reduced bone marrow cellularity: an average 42% of the control level in LK-mice; representative data are shown in Table 2 . Clonogenic analysis of bone marrow cells in the Lvmyc2 mice revealed decreased numbers of CFU-GMs, CFUGEMMs and BFU per femur when compared to LK animals ( Table 2) . Bone marrow cells derived from the Lv-myc2 mice exhibited reduced viability (an average 63% of control levels: 46 ± 8 vs 84 ± 4) as determined by dye exclusion. Thus decreased bone marrow cellularity in Lv-myc2-reconstituted mice appears to be due to a depletion of early progenitors (CFU-GEMMs) and later progenitors (CFU-GMs, BFU-Es).
To understand the basis of this cellularity, the parameters of cell proliferation and programmed cell death (apoptosis) were next analyzed. Multiple cells with apoptotic morphology were identified in the bone marrow and spleen of Lv-myc2-reconstituted mice ( Figure 3A, panels c, d, e and g ). Such apoptotic cells were often focally distributed, suggesting that clusters of apoptotic cells represent the progeny of proliferating cells. DNA breaks in these tissues were also analyzed and TUNEL analysis revealed multiple positively stained cells in all leukemic animals. Multiple apoptotic cells were also observed amongst transformed mononuclear cells infiltrating lungs (not shown) and liver ( Figure 3A, panel f) . The extensive apoptosis often correlated with DNA degradation in these tissues resulting in nucleosomal-sized fragments (Figure 3b,  lanes 2, 5 and 6) .
By contrast only occasional apoptotic cells ( Figure 3A , panels a, b and h) and no such DNA degradation ( Figure 3B , lanes 3 and 4) were observed in control mice. Accumulation of p53 protein was previously observed in c-myc overexpressing fibroblasts in association with apoptosis. 25 Cells strongly stained with p53-specific antibody were seen in Lv-myc2 mice but not in LK-mice (Figure 4) . We further found that many p53 positively stained cells could be identified as apoptotic: they are characterized by condensed or fragmented nuclei and are often separated from adjacent cells (Figure 4) . The expression of p21
Waf1 and bax, both identified as downstream effectors of p53 26, 27 was further analyzed. P21 positively staining cells were not observed in the spleen, bone marrow and lung of both Lv-myc2 and LK mice ( Figure  5 ). It is relevant that this p21 antibody demonstrated moderate positive nuclear staining in the liver of both Lv-myc2 and LK reconstituted mice ( Figure 5 ). In contrast, strong bax-positive cytosolic staining was readily detected in all Lv-myc2-reconstituted mice in spleen, liver, lung and bone marrow in association with apoptosis while only occasional bax-positive apoptotic cells were observed in the spleen of LK reconstituted mice ( Figure 6 ). In many cases bax expression was colocalized with p53 expression (Figure 6 ). It is relevant that bax staining was also observed in p53 negative cells indicating possible p53-independent induction of bax.
Apart from apoptosis, multiple PCNA-positive cells were observed in the bone marrow and spleen of all leukemic mice ( Figure 7 ). The levels of proliferation (defined by PCNA index) and apoptosis (defined by TUNEL analysis) of both were much higher in the Lv-myc-2 reconstituted mice compared to their LK counterparts (Table 3) .
Comparison of Lv-myc2 and LNAV-myc reconstituted mice
The Lv-myc2-reconstituted mice were compared with mice reconstituted with LNAv-myc-infected bone marrow. The use of this virus has been previously shown to induce myeloproliferative disorders or leukemia. 1 In the present series of experiments, of the 12 LNAv-myc-reconstituted mice tested, six developed myyeloproliferative disorders and two leukemia with a latency of 7-27 weeks, consistent with previous findings.
1 Four LNAv-myc-reconstituted animals remained healthy and these were shown to be provirus-negative. Multiple apoptotic cells were identified in the spleen tissue of the four mice with myeloproliferative disorders and in one of the two with leukemia. In the other three animals the apoptotic level was similar to that of the control (data not shown).
When five lethally irradiated mice were transplanted with a suboptimal number (1.5 × 10 5 ) of Lv-myc2-infected bone marrow cells and SCF was omitted in the ex vivo culture, only one mouse developed leukemia 18 weeks after reconstitution. Four other mice became severely ill 2-4 weeks following transplantation. Autopsy revealed pale internal organs, brittle white bones and markedly reduced cellularity in spleen and bone marrow (data not shown). Histology revealed abnormal irregular splenic architecture and multiple cells with apoptotic morphology ( Figure 3A) . Similar results were found with the three survivors in the further series of five animals (data not shown). Given that two control mice reconstituted with the similar amount of LK-infected bone marrow cells did not exhibit signs of disease we concluded that hematopoietic reconstitution was unsuccessful in these four mice due to extensive apoptotic cell death associated with v-myc expression. Thus apoptosis appears to be a primary response to v-myc expression in those mice which were reconstituted with a suboptimal number of Lv-myc2-infected cells, cultured under growth restrictive conditions.
Discussion
The results show that a simple novel v-myc-carrying retrovirus (Lv-myc2) modelled on a spontaneously generated recombinant retrovirus 1, 14 is efficiently expressed in the hematopoietic tissues of all Lv-myc2-reconstituted mice. Proviral DNA was detected in 70-80% of the myelomonocytic progenitors (CFU-GM) derived from Lv-myc2-infected bone marrow confirming high transduction efficiency.
All Lv-myc2-reconstituted mice became moribund and developed severe leukemia rather than myeloproliferative disorders within a short period following reconstitution (5-11 weeks). In contrast, only eight of the 12 LNAv-myc-reconstituted mice developed disease with longer latency (7-27 weeks post-reconstitution) and only a proportion of the eight developed leukemia. These results are consistent with previous experiments in which 11 of 17 LNAv-myc-reconstituted animals developed disease after a latency period of 4-23 weeks and only a proportion developed leukemia.
1 Thus Lvmyc2 appears to be more efficient in the induction of leukemia (both in terms of disease and time of onset) in bone marrow reconstituted mice.
Deregulated myc expression has been shown to be associated with accelerated cell death through apoptosis when cells were deprived of growth factors. 8, 9 It has been proposed that the abrogation of myc-induced apoptosis is associated with tumor development. 6, 13 Previous results from this group have shown that constitutive production of colony-stimulating factor-1 (CSF-1) in v-myc-transformed murine myelomonocytes is associated with neoplastic progression 28 and that this constitutive growth factor production abrogates apoptosis in these cells. 29 In addition, we have found that the mouse tumors which developed following the injection of v-myctransformed myelomonocytes, were derived from cells with a functionally intact apoptotic mechanism. 29 The results reported here indicate that apoptosis, a part of the cellular response to v-myc expression does not prohibit leukemia development. It is relevant that extensive apoptosis was observed during lymphomagenesis in E-myc transgenic mice 30 and in Burkitt's lymphoma with deregulated c-myc. 31 Reduced numbers of B cells, associated with a high degree of apoptosis in bone marrow, have been shown to be a characteristic feature of the preneoplastic period in E-myc transgenic mice. 32 The physiological relevance of v-myc-induced apoptosis is unclear. It is relevant that other dominant oncogenes such as adenoviral E1A, also induce apoptosis in infected cells. 33 These results were confirmed when apoptosis was observed in mice that were transplanted with 'sub-optimal' cells (presumably due to insufficient numbers of progenitors) in which leukemia did not develop. Apoptosis appears to represent a primary response to v-myc expression since those mice which were reconstituted with a sub-optimal number of Lv-myc2-infected cells exhibited extensive apoptosis in the absence of leukemia. Apoptosis was not observed in three of the eight LNAv-myc-reconstituted mice which developed disease. This is consistent with previous results in which growth factor independent cell lines could be derived relatively easily from LNAv-myc-reconstituted mice, 1 suggesting that in these cases the apoptotic mechanism normally activated by growth factor withdrawal has been circumvented during leukemia progression. It is relevant that the alterations in the expression of the apoptotic pathway accompany neoplastic progression in Burkitt's lymphoma associated with deregulation of c-myc. 31 The present results show that v-myc induces hyperproliferation or apoptosis in primary bone marrow cultures depending on the availability of growth factors. CFU-GM were enhanced by v-myc in the presence of IL-3 and inhibited in the absence of IL-3, presumably due to apoptosis. A similar dual effect of v-myc expression was observed in bone marrow reconstituted mice. It is most likely, and the in vitro data supports this conjecture, that whether v-myc-expressing cells are driven into cell cycle or apoptosis depends on the local growth factor supply provided in the microenvironment. It is relevant that the accelerated neoplastic progression in Emyc-transgenic mice was associated with hyperproliferation rather than with deregulation of apoptosis. 34 Accumulation of p53 protein was observed in all of the Lvmyc2-reconstituted mice correlating with the increased degree of apoptosis. p53-positive cells, however, were less abundant than apoptotic cells. This may indicate that p53-independent apoptosis also occurs. To the best of our knowl- edge this is the first demonstration of p53 accumulation in response to activated myc in vivo. p53 accumulation has also been observed in c-myc overexpressing fibroblasts and in adenovirus E1A-expressing cells and in those cases was also found to be associated with apoptosis. 25, 33 Both E1A-and cmyc-induced accumulation of p53 appears to be due to protein stabilization rather than to transcriptional activation. 25, 33 The expression of p21
Waf1 and bax, both identified as downstream effectors of p53, 26, 27 was also analyzed. p21 Waf1 encodes a cyclin-dependent kinase inhibitor and its expression can be induced through a p53-dependent pathway. 26 In the reconstituted mice, p21 was not observed in apoptotic cells. It is relevant that myc-mediated apoptosis in primary embryo fibroblasts requires wild-type p53 in a manner independent of both cell cycle arrest and the ability of p53 to induce p21 Waf1 . 35 However, v-myc-mediated suppression of p53-dependent p21 induction can not be excluded. By contrast, bax expression correlated with apoptosis and p53 accumulation in Lv-myc2-reconstituted mice indicating an involvement of bax in v-myc-induced apoptosis.
Taken together, these results indicate that apoptosis appears to represent a primary response to v-myc and that this does not prevent leukemia development. Hyperproliferation rather than abrogation of oncogene-induced apoptosis appears to be a critical event in v-myc-induced leukemia. These results are relevant to consideration of chemotherapeutic approaches to a b
Figure 7
Cell proliferation in the spleen of reconstituted mice. Sections were stained with PCNA specific antibody (a) LK; (b) Lv-myc2. Arrows indicate positively stained cells. DAB instead of AEC was used as a substrate for immunoperoxidase and sections were not counterstained. Microphotographs were taken at 20× objective with 10× eyepiece magnification.
oncogene-induced leukemia and may indicate that, in terms of potential therapy, the balance needs to be shifted towards apoptosis.
